MedWellAI (MWAI) Shares Outstanding (Weighted Average) (2011 - 2026)

MedWellAI (MWAI) has 16 years of Shares Outstanding (Weighted Average) data on file, last reported at $6.2 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $6.2 million, up 13.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.2 million (up 13.43% YoY), and the FY2025 annual result was $6.2 million, up 40.19% from the prior year.
• Shares Outstanding (Weighted Average) rose to $6.2 million in Q1 2026 per MWAI's latest filing, from $130000.0 in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $6.2 million in Q1 2026 and troughed at $1125.0 in Q4 2024.
• A 5-year average of $2.9 million and a median of $2.2 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) sank 99.12% in 2022, then soared 11455.56% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.0 million in 2022, then climbed by 12.3% to $2.2 million in 2023, then plunged by 99.95% to $1125.0 in 2024, then soared by 11455.56% to $130000.0 in 2025, then soared by 4697.37% to $6.2 million in 2026.
• Business Quant data shows MWAI's Shares Outstanding (Weighted Average) at $6.2 million in Q1 2026, $130000.0 in Q4 2025, and $500000.0 in Q3 2025.